^“p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities”. Molecular Cell2 (3): 305–16. (September 1998). doi:10.1016/S1097-2765(00)80275-0. PMID 9774969.
^“Cloning and functional analysis of human p51, which structurally and functionally resembles p53”. Nature Medicine4 (7): 839–43. (July 1998). doi:10.1038/nm0798-839. PMID 9662378.
^“NBP is the p53 homolog p63”. Carcinogenesis22 (2): 215–9. (February 2001). doi:10.1093/carcin/22.2.215. PMID 11181441.
^“p53CP is p51/p63, the third member of the p53 gene family: partial purification and characterization”. Carcinogenesis22 (2): 295–300. (February 2001). doi:10.1093/carcin/22.2.295. PMID 11181451.
^“DeltaNp63alpha and TAp63alpha regulate transcription of genes with distinct biological functions in cancer and development”. Cancer Research63 (10): 2351–7. (May 2003). PMID 12750249.
^“Dedicated protection for the female germline”. Nature Reviews Molecular Cell Biology8 (1): 4–5. (January 2007). doi:10.1038/nrm2091.
^“p63 in epithelial survival, germ cell surveillance, and neoplasia”. Annual Review of Pathology5: 349–71. (2010). doi:10.1146/annurev-pathol-121808-102117. PMID 20078223.
^“DNA damage in oocytes induces a switch of the quality control factor TAp63α from dimer to tetramer”. Cell144 (4): 566–76. (February 2011). doi:10.1016/j.cell.2011.01.013. PMC 3087504. PMID 21335238. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3087504/.
^“TAp63 is important for cardiac differentiation of embryonic stem cells and heart development”. Stem Cells29 (11): 1672–83. (November 2011). doi:10.1002/stem.723. hdl:2066/97162. PMID 21898690. オリジナルの2014-08-08時点におけるアーカイブ。. https://web.archive.org/web/20140808060204/http://minus.com/lNWTY9g2q5yYG.
^“PERP-ing into diverse mechanisms of cancer pathogenesis: Regulation and role of the p53/p63 effector PERP”. Biochim Biophys Acta Rev Cancer1874 (1): 188393. (Dec 2020). doi:10.1016/j.bbcan.2020.188393. PMID 32679166.
^“Refinement of evolutionary medicine predictions based on clinical evidence for the manifestations of Mendelian diseases”. Scientific Reports9 (1): 18577. (December 2019). Bibcode: 2019NatSR...918577S. doi:10.1038/s41598-019-54976-4. PMC 6901466. PMID 31819097. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6901466/.
^“Impaired epithelial differentiation of induced pluripotent stem cells from ectodermal dysplasia-related patients is rescued by the small compound APR-246/PRIMA-1MET”. Proceedings of the National Academy of Sciences of the United States of America110 (6): 2152–6. (February 2013). Bibcode: 2013PNAS..110.2152S. doi:10.1073/pnas.1201753109. PMC 3568301. PMID 23355677. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3568301/.
^“p63 cooperates with CTCF to modulate chromatin architecture in skin keratinocytes”. Epigenetics & Chromatin12 (1): 31. (June 2019). doi:10.1186/s13072-019-0280-y. PMC 6547520. PMID 31164150. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6547520/.
^“p63 as a complementary basal cell specific marker to high molecular weight-cytokeratin in distinguishing prostatic carcinoma from benign prostatic lesions”. The Medical Journal of Malaysia62 (1): 36–9. (March 2007). PMID 17682568.
^“Immunohistochemical antibody cocktail staining (p63/HMWCK/AMACR) of ductal adenocarcinoma and Gleason pattern 4 cribriform and noncribriform acinar adenocarcinomas of the prostate”. The American Journal of Surgical Pathology31 (6): 889–94. (June 2007). doi:10.1097/01.pas.0000213447.16526.7f. PMID 17527076.
^“Distinction of pulmonary small cell carcinoma from poorly differentiated squamous cell carcinoma: an immunohistochemical approach”. Modern Pathology18 (1): 111–8. (January 2005). doi:10.1038/modpathol.3800251. PMID 15309021.
^Martin SE, Temm CJ, Goheen MP, Ulbright TM, Hattab EM (2011). “Cytoplasmic p63 immunohistochemistry is a useful marker for muscle differentiation: an immunohistochemical and immunoelectron microscopic study.”. Mod Pathol24 (10): 1320–6. doi:10.1038/modpathol.2011.89. PMID 21623385.
^“P63 alpha mutations lead to aberrant splicing of keratinocyte growth factor receptor in the Hay-Wells syndrome”. The Journal of Biological Chemistry278 (26): 23906–14. (June 2003). doi:10.1074/jbc.M300746200. PMID 12692135.
^“miRNAs, 'stemness' and skin”. Trends in Biochemical Sciences33 (12): 583–91. (December 2008). doi:10.1016/j.tibs.2008.09.002. PMID 18848452. オリジナルの2013-04-21時点におけるアーカイブ。. https://archive.today/20130421181244/http://min.us/lGvvAc29SY8ux.
^Prieto-Garcia, C.; Hartmann, O; Reissland, M.; Braun, F.; Fischer, T.; Walz, S.; Fischer, A.; Calzado, M. et al. (Jun 2019). “The USP28-∆Np63 axis is a vulnerability of squamous tumours” (英語). bioRxiv: 683508. doi:10.1101/683508. https://www.biorxiv.org/content/10.1101/683508v1.
^“Maintaining protein stability of ∆Np63 via USP28 is required by squamous cancer cells”. EMBO Molecular Medicine12 (4): e11101. (March 2020). doi:10.15252/emmm.201911101. PMC 7136964. PMID 32128997. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7136964/.
関連文献
“p63”. The International Journal of Biochemistry & Cell Biology34 (1): 6–9. (January 2002). doi:10.1016/S1357-2725(01)00086-3. PMID 11733180.
“Mutations in the p53 homolog p63: allele-specific developmental syndromes in humans”. Trends in Molecular Medicine8 (3): 133–9. (March 2002). doi:10.1016/S1471-4914(01)02260-2. PMID 11879774.
“Splitting p63”. American Journal of Human Genetics71 (1): 1–13. (July 2002). doi:10.1086/341450. PMC 384966. PMID 12037717. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC384966/.
“P63 gene mutations and human developmental syndromes”. American Journal of Medical Genetics112 (3): 284–90. (October 2002). doi:10.1002/ajmg.10778. PMID 12357472.
“Neuronal survival and p73/p63/p53: a family affair”. The Neuroscientist10 (5): 443–55. (October 2004). doi:10.1177/1073858404263456. PMID 15359011.
“The soluble p51 protein in cancer diagnosis, prevention and therapy”. In Vivo19 (3): 591–8. (2005). PMID 15875781.
“ΔNp63 is an ectodermal gatekeeper of epidermal morphogenesis”. Cell Death and Differentiation18 (5): 887–96. (May 2011). doi:10.1038/cdd.2010.159. PMC 3131930. PMID 21127502. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3131930/.